Miss Nicola Fearnhead has been a Consultant Colorectal Surgeon at Addenbrooke's Hospital, Cambridge since 2006. She is a graduate of Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was undertaken in Bristol and Oxford followed by an International Fellowship in Advanced Colorectal Surgery at the Cleveland Clinic, Ohio, USA in 2005.
Subspecialty interests include advanced pelvic malignancy and exenteration surgery, transanal endoscopic microsurgery, management of anal cancer including salvage surgery, laparoscopic colorectal surgery, inflammatory bowel disease and especially perianal Crohn's disease, pelvic floor disorders including rectovaginal fistula repair, intestinal failure and functional bowel disorders.
Research interests include genetic predisposition to colorectal cancer, functional outcomes after anal cancer treatment, perianal Crohn's disease and clinically-based surgical research in a wide number of areas. She led the ACPGBI's development of a research strategy with integrated patient and public involvement (the Delphi Research Programme) while Chair of ACPGBI's Research & Audit Committee from 2013-2017. She was awarded the Patient Liaison Group's Patient Champion Award in 2017. She is also a member of the NCRI Colorectal CSG surgical subgroup. She serves on the trial management groups of HiP, CReST2 and PREPARE-ABC.
She chairs the Clinical Advisory Group for the National Bowel Cancer Audit and led the national programme for Consultant Outcome Publication in bowel cancer surgery on behalf of the ACPGBI from 2014 to 2016. She has been Honorary Secretary of ACPGBI's IBD Clinical Advisory Group since 2016, and co-authored the 2017 Ileoanal Pouch Report. She was selected for the RCS Emerging Leader's programme in 2015 and sits on the RCS Fellowships Committee.
Nicola Fearnhead is currently President-in-Waiting of ACPGBI, Chair of the Steering Group for the collaborative-led National Audit of SBO, co-convenor of the IMPACT initiative and a Trustee of the Bowel Disease Research Foundation. She also serves as a medical adviser to Bowel Cancer UK and Crohn's and Colitis UK.